Author's posts
The Dr. Fauci Of The 1918 Spanish Flu
More than a century ago, epidemiologist Dr. Thomas Tuttle prescribed face masks and social distancing to slow the influenza pandemic. He made a lot of enemies—but it worked.
Scientists And CEOs, Professors And Priests: Strategies From The Pandemic Frontlines
As the coronavirus spreads across the globe and threatens to be the biggest pandemic since 1918’s Spanish Flu, accurate information from the people on the front lines of research, medicine and policy are vital.
‘We’ll See Some Pretty Big Changes’: How One Top Biotech Investor Eyes Healthcare In A Post-Coronavirus World
Arch Venture Partners’ managing director Kristina Burow sees the healthcare sector poised to come out stronger as it innovates against COVID-19.
The Secret History Of The First Coronavirus
In 1965, researchers discovered a vexing respiratory infection called 229E. Today, we know it as the common cold.
FDA Greenlights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients
Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem cell therapy against COVID-19.
On National Doctors’ Day, 15 Heroic Firsthand Stories From The Coronavirus Front Lines
On a day set aside to honor doctors, Forbes presents the stories of the men and women who are working day and night across the country fighting against the pandemic.
What Are The Symptoms Of COVID-19 Coronavirus, And When Should You See A Doctor?
As COVID-19 spreads throughout the world, here are the symptoms that may indicate you’ve been exposed.
How Bad Will The COVID-19 Coronavirus Epidemic Get In The U.S.? Health Experts Weigh In
A lack of testing and inconsistent responses make it hard to predict how bad the new coronavirus outbreak will get in the U.S., but social distancing measures will slow it down.
Coronavirus Drug Update: The Latest Info On Pharmaceutical Treatments And Vaccines
Forbes is tracking a definitive list of the pharmaceutical companies and startups working to find treatments and vaccines for the COVID-19 coronavirus.
With RxDefine, This Under 30 Cofounder Is Moving From Manufacturing To Healthcare
Forbes Under 30 alumnus Chase Feiger has raised over $11 million to build a new business, this time aimed at providing a direct-to-consumer platform for pharmaceutical companies.
